caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1376511980

Mark Moster

OphthalmologyPhiladelphia, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Mark Moster's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 9 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Robert Sergott
Ophthalmology · Philadelphia, PA
142268
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Norristown, PA
78200
THOMAS JEFFERSON UNIVERSITY HOSPITALS INC60119
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
57115
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Norristown, PA
80188
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
54103
THOMAS JEFFERSON UNIVERSITY HOSPITALS INC2435
Robert Sergott
Ophthalmology · Philadelphia, PA
2029
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA1841
VIRTUA - WEST JERSEY HEALTH SYSTEM, INC.1638
ABINGTON MEMORIAL HOSPITAL1648
MAIN LINE HOSPITALS, INC.1140
Anish Koka
Cardiology · Philadelphia, PA
1135
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
76
Beneficiaries
—
Total drug cost
$4K
Distinct drugs
2
Brand share
0.0%
Top prescribed drugs
Pyridostigmine Bromide42 claims
Prednisone34 claims
QUALITY · MIPS · 2024
Final MIPS score
87.3
Quality
80.8
Cost
76.9
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.52%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$4K
Payment records
10
By payment type
Consulting Fee$3K
Food and Beverage$860